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 The Abl pathway is involved in many functions within a cell, including axon pathfinding 
and maintaining the neuronal cytoskeleton. These functions imply a requirement of functional 
Abl protein within a cell, however, flies that are homozygous mutant for Abl survive to 
adulthood, although at reduced frequencies. Previous studies have uncovered multiple dosage-
dependent modifiers of the Abl- phenotype, which can either enhance lethality, shifting it toward 
an earlier developmental stage, or suppress the phenotype, reducing lethality. These studies have 
yet to examine the effect polymorphic variation within natural population lines has on the 
dosage-dependent modification of Abl- phenotype. This study utilizes the inherent genetic 
variation of the Drosophila Genetic Reference Panel (DGRP) to carry out this analysis. With 
roughly 200 isogenic lines, the DGRP provides ample natural variation to carry out this 
investigation. We utilized six sensitized genotypes, five using a balancer chromosome containing 
the dominant marker, Tubby (Tb), and one using a chromosome containing the dominant marker 
Drop (Dr). Each genotype allowed us to observe the effect of natural polymorphic variation on 
the Abl- phenotype in different ways. We found that the interaction of the DGRP’s inherent 
natural variation and the sensitized backgrounds did affect relative fitness. We also examined the 
correlation of mean fitness ratios between each genotype and found a range of correlations 
between multiple genotypes. Calculations of variance both between and within DGRP lines 
found that total phenotypic variation that was due to genetic differences was surprisingly low. 
The relative viability of each line in each sensitized background was used in a genome-wide 
association (GWA) analysis. The GWA analysis produced a list of nearly 200 single nucleotide 




SNPs occurred in over 100 genes. Additionally, five of those genes were shared between several 
genotypes.  
Introduction 
The generation of a nervous system is an incredibly complex, highly regulated process 
requiring the interactions of hundreds of proteins. While comparatively simpler than vertebrates, 
Drosophila embryos require the same underlying neural processes to survive (Howard, et al., 
2019).To successfully develop, an embryo must coordinate the specification of multiple types of 
neurons while also controlling how each neuron connects to each other and other cells (Howard, 
et al., 2019). Guidance of axon growth is controlled through responses to attractive and 
repressive guidance cues, which guide axons via neuronal receptors to their target regions. Most 
of these axons are commissural, meaning they cross the midline once to innervate targets on the 
other side of the embryo and do not cross the midline again (Howard, et al., 2019). There are a 
host of signaling pathways that regulate guidance to and repulsion from the midline, as axons 
that aberrantly cross or fail to cross the midline will lead to neural defects.  
A signaling protein of particular interest to this study is the Abelson (Abl) tyrosine 
kinase. The cytoplasmic protein is involved in regulating many crucial cell functions, including 
axon outgrowth and dynamics of the axon cytoskeleton (Liebl, et al., 2003). Abl interacts with 
multiple other genes to facilitate axon pathfinding, such as Failed Axon Connections (Fax), Trio, 
Amalgam (Ama), and Neurotactin (Nrt) (Liebl, et al., 2000) (Liebl, et al., 2003) (Hill, et al., 
1995) (Gertler, et al., 1993). Abl is expressed in most tissues during embryogenesis, and in later 
stages of development, it is localized to the axons of the CNS (Bennett , et al., 1992). Its 
abundance in developing tissues and extensive interactions implies a necessity of functional 




frequencies, suggesting redundancies in these pathways (Hill, et al., 1995). Through genetic 
enhancer/suppressor screens, dosage-sensitive modifiers of the Abl- phenotype have been 
discovered that increase lethality, shifting it toward an earlier developmental stage (Gertler, et 
al., 1993). For example, flies that are homozygous mutant for Abl and heterozygous mutant for 
Nrt die before the pupal stage and exhibit defects in axon pathways within the CNS, although 
peripheral nervous tissue appears normal (Liebl, et al., 2000). Similarly, heterozygous null 
mutations of Trio dominantly enhance the Abl- phenotype (Liebl, et al., 2000). Dominant 
suppression of the Abl- phenotype can also occur. Genetic screens have shown that Enabled is a 
dominant dosage-dependent suppressor of the Abl- phenotype (Gertler, et al., 1995).  
Dosage-dependent modification of the Abl- phenotype has been a frequent target of 
genetic screens. This study aims to identify how polymorphic variation that exists within 
Drosophila natural populations can modify the Abl- phenotype. While past screens have focused 
on how single genes can act as modifiers, this study will be examining combinations of 
polymorphisms that exist in isogenic lines derived from a natural population. A previous study in 
this lab examined how polymorphic variation within the Drosophila Genetic Reference Panel 
(DGRP) can affect development of the embryonic CNS axon scaffolding (Gosztyla, 2018). We 
aim to build on this investigation by utilizing a similar analysis of the effect of the DGRP’s 
inherent variation as dosage-dependent modifiers of the Abl phenotype.   
Access to genetically diverse Drosophila lines was made easy through the establishment 
of the Drosophila Genetic Reference Panel (DGRP). In 2012, researchers created the DGRP 
using a natural population of flies from Raleigh, North Carolina. By selectively inbreeding the 
flies, the group was able to create over 200 different isogenic lines (Mackay, et al., 2012). 




over 4.6 million single nucleotide polymorphisms (SNPs), 100,000 polymorphic microsatellite 
sites, and over 30,000 transposable element insertion sites (Mackay, et al., 2012). Additionally, 
the genome of each line has been fully sequenced, allowing for the correlation of phenotypes 
with specific genetic variants. Previous GWA studies have demonstrated that the DGRP has 
substantial natural genetic variation that impacts diverse phenotypes (Mackay, et al., 2018).  In 
this study, a GWA analysis will allow for the identification of polymorphisms that affect 
viability in different sensitized Abl mutant pathway backgrounds.  
The DGRP is a useful tool to analyze gene function. Previous studies have shown that 
mutations can produce a variety of phenotypes due to the underlying genetic variation of the 
background in which they are expressed (Mackay, 2014). This approach can also identify genes 
that are typically missed due to functional redundancy or epistatic interactions. Since its creation, 
the DGRP has been used to exploit natural variation to assist in the identification of genetic 
modifiers of specific genes. Recently, the variability of the retinal phenotype RhlG69D was studied 
using these mechanisms, and over 100 candidate modifier genes were identified (Chow, et al., 
2016). Our study will also utilize the advantages of the DGRP to analyze how genetic variation 
can affect the ability of enhancers to modulate the Abl- viability phenotype. This analysis may 
allow for the identification of unknown genes that are components of the Abl pathway.  
Methods 
This study examined the effect of natural polymorphic variation within the DGRP on 
relative fitness in different Abl mutant backgrounds. This was accomplished by mating five to 
six virgin females from a DGRP line with three to four males which contained a sensitized 
mutant chromosome along with a balancer chromosome encoding a dominant marker. Five 




document), Abl1/TM6B,Tb (Abl1), Abl4/TM6B,Tb (Abl4), P[Abl+]; Abl1, NrtM54/TM6b,Tb 
(referred to as Rescue throughout the document), and Comm,Comm2Delta14/TM6B,Tb (referred to 
as Delta 14 throughout the document). The Delta 14 genotype harbors a deletion of the adjacent 
Comm and Comm2 genes (Seeger Lab unpublished). The Rescue genotype includes an Abl+ 
transgene, inserted on the second chromosome, that rescues phenotypes associated with the Abl1 
allele on the third chromosome. Additionally, a Dr genotype was created by mating five to six 
DGRP females to a single male containing +/CyO; Abl1 NrtM54/Dr. The Tb dominant marker 
created shortened pupae, while the Dr marker created adult flies with small eyes. Both markers 
allowed for easy scoring of the progeny.  
The Abl1 and Abl4 genotypes were created to show the effect that natural polymorphic 
variation has on different Abl alleles. The Abl Nrt genotype was used to show if any of those 
effects could be contributed to Nrt, as the only difference between Abl1 and Abl Nrt was the 
presence of the NrtM54 allele. The Rescue genotype included a wild-type copy of Abl with the 
Abl Nrt chromosome, to test if normal viability could be “rescued” with the addition of 
functional Abl. The Delta14 genotype served as a control, as deletions in the two Comm genes 
aimed to test how mutations in other neuronal genes would affect viability. The Dr genotype 
served as an additional control by testing if the viability of the other genotypes could be 
attributed to interactions with the Tb chromosome.  
Flies were brooded at four and eight days after mating, and vials were cleared after 12 
days. At 15-16 days after egg laying, the progeny were scored. Scoring involved counting the 
number of Tb- and Tb+ pupae on the walls of the vials. For the Abl Nrt genotype, at least five 
scored crosses per line with a minimum of 50 pupae total was set as a threshold for our 




scored with a minimum of 50 pupae scored per cross. Adult progeny from crosses using the Dr 
marker were sorted and counted in four categories: Dr+ and Dr- females, and Dr+ and Dr- males, 
and only flies that were Cy+ were scored. Adult flies were scored for the final time at 20 days 
after egg laying. The more restrictive end point of scoring for Dr flies meant that a different 
endpoint is being accessed. Tb flies only had to survive to the pupal stage, while Dr flies had to 
survive to adulthood.  
After total calculations were complete for each DGRP line with each of the genotypes, 
the data was entered into Excel for analysis. The total count of pupae/flies was entered, along 
with the date of the initial cross. The ratio of Tb+/Tb- or Dr+/Dr- flies was calculated for each 
dated entry, and the mean Tb+/Tb- or Dr+/Dr- ratio within each DGRP line was also calculated. 
The standard deviation of the individual ratios, the mean count of flies in each category, and the 
standard deviation of the mean count of flies were also calculated for each line. The correlation 
of these relative viability ratios to the total number scored for each cross was also included. A 
sample data entry table can be seen in Table 1.  
This data was condensed into a table that contained each DGRP line, its mean ratio, 
standard deviation of ratios, correlation, mean count, and standard deviation of mean counts, and 
was repeated for each genotype. Calculations were only done on DGRP lines that had at least 
three dated entries (five for Abl Nrt) with a minimum total of 50 pupae/adults counted. Lines 
with less than three entries were still added into Excel but were not included in data analysis. The 
mean Tb+/Tb- or Dr+/Dr- ratio was our main focus of data analysis. Each line’s mean ratio for a 
genotype was sorted into increasing order and was graphed for each genotype. Additionally, 
graphs showing the correlation of a line’s mean ratio between sensitized backgrounds were also 




calculated. Average variation within lines was calculated as the squared mean of individual line 
standard deviations. Variation between lines was found by calculating the standard deviation of 
all the mean ratios for a sensitized background and squaring the value. The number of lines with 
ratios above and below 1.0 was calculated and placed into a table, and a table including the 
differences between the largest and smallest ratios for each genotype was produced. Finally, a 
table containing a ranked order list of the mean ratios for each genotype was created.   
 DGRP lines paired with their mean ratios were submitted to the DGRP2 pipeline for 
GWA analysis (http://dgrp2.gnets.ncsu.edu). This pipeline shows SNP results that have a p-value 
of at least 10-5. Minor alleles with a frequency below 5% were not included in the results. The 
SNP data was condensed into a table which contains the SNP name, its site annotation (intron, 
exon, 5’UTR, among others), the gene name where the SNP occurs (if applicable), the p-value, 
and the sensitized backgrounds the data originated from.  
Results/Discussion 
The distribution of mean Tb+/Tb- ratios with the Abl Nrt sensitized background appears 
linear for most of the data set, but as the mean ratios near the upper quartile, the data begins to 
increase exponentially (Figure 1). The majority of lines within this genotype had mean Tb+/Tb- 
ratios below 1.0 (Table 3). Lines with a ratio above 1.0 contained fewer flies with the Tb 
balancer chromosome than without, and therefore contained more flies with the mutated Abl Nrt 
genotype than without. In these lines, the chromosome with the Abl Nrt mutation had a higher 
relative fitness. As the majority (63%) of Abl Nrt lines had a ratio below 1.0, mutations in both 
Abl and Nrt appear to be deleterious and the relative fitness of flies carrying both mutations was 
decreased (Table 3). The variation of mean ratios within lines of the Abl Nrt genotype was larger 




throughout all genotypes. Variation between lines describes the genetic component of phenotypic 
variation, and variation within lines describes environmental effects. As variation within lines 
was consistently larger than between lines, it indicates that the observed phenotypic variation 
was due more to environmental effects than genetic differences. To further investigate this, total 
phenotypic variation was also found for each genotype. By dividing the between line variation 
by total phenotypic variation, we were able to estimate how much of the total phenotypic 
variation can be attributed to genetic differences. These results were also consistently low (Table 
5). We anticipated the percentage of phenotypic variation due to genetic differences to be higher 
than what we observed, implying that we underestimated the role of nongenetic differences in 
the total phenotypic variation. We also expect that the large variation found within lines limited 
our ability to identify variation between lines. The range of ratios across the DGRP was also 
relatively small, further hindering our ability to identify genetic variation.  
Abl1 and Abl4 both had a majority of lines with mean ratios above 1.0, indicating that 
mutations in only the Abl allele were not a deleterious as mutations in both Abl and Nrt. The 
distribution of mean Tb+/Tb- or Dr+/Dr- ratios was unique to each genotype, as was the number 
of lines with ratios above or below 1.0 (Figures 1-2, Table 3). However, each genotype followed 
a basic pattern of gradually increasing ratios up until the last few lines, where ratios began to 
increase much more rapidly (Figures 1-2). Between all the genotypes, no ratio was lower than 
0.475 and no ratio was larger than 2.972. The average difference between the largest and 
smallest mean ratios throughout all genotypes was 1.56 (Table 4). Overall, 57% of lines 
throughout all genotypes had mean ratios above 1.0. The distribution of mean ratios was the 
most extreme within the Delta 14 genotype. Within that genotype, only four lines had ratios 




not as deleterious of a mutation as any of the Abl mutations. Among the Abl mutant genotypes, 
Abl4 had the highest relative fitness, with 87% of DGRP lines having a mean Tb+/Tb ratio above 
1.0 (Table 3).  
Ranked-order lists of mean Tb+/Tb ratios in each genotype were produced to further 
examine the mutant genotype’s role in affecting viability. The highest-ranking mean Tb+/Tb ratio 
within a genotype, which was the line that showed the highest relative fitness with the mutant 
genotype was ranked 1 (Table 2). The genotypes we introduced into the DGRP backgrounds do 
seem to influence the viability ratios. The effect on viability did not need to be in one direction. 
The interaction of natural polymorphisms within the DGRP and the mutant genotypes could have 
increased or decreased relative fitness. We were interested in examining the extent of that 
interaction, not its direction. Many lines had considerable differences in their mean Tb+/Tb- 
ratios between genotypes (Table 2). However, some lines did show consistency in their rankings. 
Line 374 was in the bottom 5% of lines for four of the five genotypes and was in the bottom 
quartile for the fifth genotype (Table 2). Conversely, line 714 was consistently ranked in the top 
10 for every genotype (Table 2). Lines whose rankings did not change much indicate that their 
background variation’s interaction with the genotype of the sensitized background was minimal. 
It also implies that the interaction of the DGRP polymorphisms with the Tb chromosome was the 
major driver of relative fitness, instead of interactions between the DGRP and sensitized 
backgrounds. We hypothesized that the genotype with the greatest impact on viability would be 
Abl Nrt, followed by Abl1, and Abl4. This pattern was seen in some lines and was absent in 
others. Line 427 follows this pattern, as its interaction with mutant genotypes was most extreme 
with Abl Nrt, followed by Abl1 and Abl4 (Table 2). The shift in ranking seen with Rescue 




is an example of a line that did not follow this pattern. It was remarkably consistent in its 
rankings, apart from Delta 14 (Table 2). In this line, the interaction of Comm or Comm2 with the 
DGRP background was more extreme than in other lines. Additionally, line 100 ranked first (the 
highest) for mean ratios in the Abl1 genotype, but was ranked near the bottom for the Abl Nrt, 
Abl4, and Rescue genotypes. This implies that mutations in Nrt in this line affected viability to a 
much lesser extent than mutations in either of the other Abl genotypes. The effect of the 
interaction of each genotype and DGRP backgrounds on viability and therefore the ranking was 
unique to each DGRP line. The lack of consistency in some genotypes makes more sense when 
considering the limited role genetic differences played in total phenotypic variation (Table 5). 
Had variation due to genetic differences had more of an effect on total phenotypic variation, we 
would expect to see much more consistent rankings within a single line. An initial comparison 
with data gathered in this lab’s previous work does not reveal consistent patterns between the 
DGRP line’s relative fitness and axon guidance defects (Gosztyla, 2018).  
 We looked for correlations of mean ratios between different sensitized backgrounds. We 
would expect that Delta 14 would not correlate with the various Abl mutant backgrounds.  This 
was observed with correlations ranging from 0.170 to 0.298 (Table 6 and Figures 6, 10, 11, and 
13). Mean ratios for Abl Nrt were correlated at a similar, mild, degree to Abl1 and Abl4, and were 
correlated much more to Rescue than to Delta14 (Table 6). We expected to see a correlation 
between the Abl mutant genotypes if changes to viability were due to Abl. As the correlation 
between Abl mutant genotypes was milder than expected, this lends further weight to the role of 
nongenetic differences in affecting viability. The effect of polymorphic variation within the 
DGRP lines on viability was most similar between Abl Nrt and Rescue, but that similarity was 




expect it to be the strongest correlation we found. There was some degree of correlation in each 
combination of lines, except for the Abl Nrt and Dr genotypes (Table 6). This was surprising, as 
we initially hypothesized that these two genotypes would show the highest degree of correlation. 
This suggests that the Dr and Tb chromosomes may be affecting viability more than we initially 
thought, and they are affecting viability in different ways. Graphs of the mean ratios between 
each combination of genotypes were created to further examine correlation (Figures 4-14). These 
again showed no extreme correlation in any pair of genotypes, however, Abl Nrt vs Abl1 and Abl 
Nrt vs Abl4 showed a slight correlation of ratios (Figures 4-5).  
 The Dr genotype’s mean Dr+/Dr- ratios were also graphed in increasing order (Figure 3). 
The shape of its distribution was similar to the other genotypes, but the change in mean ratios 
was less drastic at either end. The Dr genotype had by far the largest percentage of lines with a 
mean ratio below 1.0, indicating that the relative fitness of this genotype was much less than that 
of all other genotypes (Table 3). This may be partially explained by the more restrictive endpoint 
of scoring that we used for the Dr flies. Dr flies were scored as adults, while Tb flies were scored 
as pupae. By increasing the amount of time the flies needed to survive before being scored, we 
allowed more time for fitness to decrease due to detrimental interactions between the DGRP 
polymorphisms and sensitized backgrounds. 
 Submitting the DGRP lines paired to their mean ratios for GWA analysis produced a list 
of 187 SNPs, which occurred in 103 genes (Table 7). Each genotype was submitted individually, 
but the data was condensed together into a single table (Table 7). 47 of the SNPs did not occur 
within genes, and instead were intergenic modifiers (Table 7). This distribution is consistent with 
the distribution of polymorphisms in the DGRP. These SNPs included many transcription factor 




SNP from all genotypes occurred in an exon (Table 7). Other regions where SNPs occurred 
include 5’ and 3’ UTRs, and synonymous or non-synonymous coding regions. We did not see 
extensive overlap in the genes that the SNPs corresponded to. Of the 103 genes where SNPs 
occurred, only five were shared between different genotypes (Table 8). The less than expected 
role of genetic differences in phenotypic variation may be attributing to the difficulty in 
identifying shared genes with SNPs between genotypes. Had genetic differences accounted for a 
larger percentage of total phenotypic variation, we hypothesize that we would have found many 
more genes in common. However, all five genotypes did share genes where SNPs occurred with 
at least one other genotype. These genes were CG1887 (also known as dsb), CG32365, cv-c, 
mbl, and Pde1c (Table 8). These genes did not have specific functions within the Abl pathway 
but did control other cell functions like morphogenesis, synaptic homeostasis, cell organization, 
and neural differentiation. Interestingly, cv-c encodes a RhoGTPase activating protein (GAP), 
which interact extensively with Rho guanine nucleotide exchange factors (GEFs) (Denholm, et 
al., 2005). As Trio encodes a GEF, these proteins may interact within the cell. However, because 
cv-c was only identified in GWA results from a single genotype, we are hesitant to remark on the 
extent or significance of this interaction. Within a single genotype, it was common for a gene to 
appear more than once. For example, four SNPs from the Rescue data set occurred in the Ance-3 
gene, and four SNPs from the Abl4 genotype occurred in the osp gene (Table 7).  
Summary 
 Mean Tb+/Tb- ratios were used to examine the effect of natural variation within the 
DGRP on relative fitness within sensitized backgrounds. Lines with a mean ratio above 1.0 
contained more flies with the sensitized genotypes than with the Tb- balancer chromosome or Dr- 




seem to have an effect on viability. The extent and direction of that effect were unique to each 
genotype. The relative fitness of each genotype was also unique, as some genotypes like Abl Nrt 
had lower relative fitness, and others such as Abl1 and Abl4 had a higher relative fitness. The 
Delta 14 genotype showed the most positive effects on relative fitness, as only four lines had 
mean ratios below 1.0. We did not see an extensive correlation between the mean ratios of the 
sensitized backgrounds, which was not what we originally hypothesized. This may reflect a 
combination of interactions of the DGRP genotype with both the sensitized background and the 
Tb- balancer or Dr- chromosomes. We also saw that phenotypic variation due to genetic 
differences was much less than we originally anticipated. The large amount of variation within 
lines limited our ability to reliably identify variation between lines. This was compounded by the 
relatively limited range of mean ratios between all DGRP lines. In future extensions of this 
investigation, we aim to include a more neutral control group (an unsensitized background) that 
may help account for this effect. These control groups would allow us to establish a baseline 
value we can use to compare with different sensitized backgrounds. Relative viability is a 
difficult endpoint to assess with the DGRP. Teasing out how each DGRP line interacts with the 
Tb- balancer (or Dr- chromosome) versus the sensitized background chromosome (e.g., Abl Nrt) 
is complex, especially given the large contribution of environmental variation to the total 
phenotypic variance. We have concluded that additional and better controls would be helpful in 







Table 1. The Excel table built for DGRP line 21 with the Abl Nrt sensitized background. This is a representative example of the tables built for each 
DGRP line with each sensitized background. The total column is the total count of pupae/flies for that individual dated entry.  The total row is the 
total count of pupae/flies for all dated entries. Mean of ratios was calculated by taking the average Tb+/Tb-ratio of each dated entry. Correlation is 
the correlation between the Total column and the Tb+/Tb- column. Mean count is the average of the values found in the Total column and 
represents the average pupae/flies counted between all dated entries for that DGRP line. Standard deviation of ratios and standard deviation of 
mean count represent the standard deviation of the Tb+/Tb- column and Total column, respectively. Mean of ratios, standard deviation of ratios, 
correlation, mean count, and standard deviation of mean count all did not include the values in the Total row when calculations were made.   
DGRP # Date # Tb- # Tb + Total Tb+/Tb- Mean of ratios St. Dev of ratios Correlation
St. Dev of mean 
count
Mean Count
21 11/22 65 40 105 0.615 0.722 0.352 0.790 40.96 117.8
21 11/22 64 73 137 1.141
21 11/22 82 32 114 0.390
21 2/16 84 88 172 1.048
21 3/21 43 18 61 0.419













Line Abl Nrt Abl 1 Abl 4 Rescue
Delta 
14
21 168 154 50 105 114
26 47 36 63 56 67
31 23 68 34 27 74
32 22 123 118 94 125
38 72 62 88 74 50
40 105 115 173 112 24
41 176 34 180 157 130
42 116 6 126 48 42
45 164 161 5
57 62 125 38 84 146
59 87 75 161 137 12
69 154 70
73 12 49 81 117 152
75 56 63 141 168 138
83 82 72 76 135 71
85 113 131 31 118 91
88 13 15 9 24 66
91 64 138 171 70 126
93 21 33 97 54 78
100 132 1 178 116 22
101 84 38 56 102 11
105 122 94 74 133 175
109 107 163 72 152 170
129 160 18 25 29
136 126 150 88 107
138 181 130 142 129 100
142 81 92 168 125 158
149 52 44 8 16 95
153 129 126 18 53 112
161 115 148 157 127 167
177 163 16 15 136 119
181 155 86 33 13 38
189 80 173 22 167
195 70 41 43 12 173
208 28 81 45 17 21
217 10 3 36 6
227 169 117
228 40 168 147 146 172
229 60 113 129 58 49
235 38 71 32 73 103
237 111 129 39 52 106
Line Abl Nrt Abl 1 Abl 4 Rescue
Delta 
14
239 101 124 104 144 143
256 16 28 20 18 2
280 166 26 169 79 18
287 11 7 11 2 72
301 145 156 78 21 168
303 182 183 176 134 164
304 144 117 37 171 145
306 27 140 105 114 153
307 165 10 78
309 123 48 3 92 97
310 110 88 146 131 9
313 63 112 54 121 111
315 131 111 160 34 51
317 147 167 65 29 57
318 95 46 7 139 109
319 24 39 68 7 8
320 26 120 73 104 116
321 5 182 51 43 88
324 73 134 44 41 179
332 187 172 172 154
335 86 32 4 68 52
336 149 141 117 142 132
338 67 103 112 120 165
340 109 116 89 166 48
348 83 161 95 49 139
350 185 184 182 181 59
352 119 97 166 160 163
354 37 27 86 143 63
355 61 57 13 26 142
356 59 80 124 133
357 29 52 149 3 127
358 171 176 151 163 68
359 14 51 48 28 28
360 103 102 93 111 141
361 136 73 110 174 176
362 174 178 158 184 73
365 17 174 59 86 160
370 169 65 154 156 44
371 98 64 165 39 174
373 146 171 99 153 150
374 184 149 184 188 182
Table 2: A ranking of each DGRP line’s mean Tb+/Tb- ratio compared to all other lines, for each genotype. The highest mean Tb+/Tb- ratio is 
ranked 1. Blank spaces indicate that the DGRP line either was not scored for that genotype or did not reach the scoring threshold. A three-
color gradient scale was used to represent values. The darkest green was used for the maximum values within the ranking, which represent 
lines with the lowest mean ratios. Red was used for lines with the highest mean ratios, and yellow was used for lines in the 50th percentile. 




Table 2. (continued) 
Line Abl Nrt Abl 1 Abl 4 Rescue
Delta 
14
559 69 87 30 77 131
563 143 162 71 113 84
566 128 165 136 177 69
584 48 96 133 59 90
589 78 60 46 71 39
595 173 166 163 150 110
596 3 177 10
627 2 10 1 5 33
630 120 132 66 182 30
634 180 179 179 147 37
639 53 22 75 15
646 102 98 107 122 94
703 130 5 103 61 25
705 65 55 47 89 32
707 51 90 91 164 108
712 186 104 152 185 155
714 1 4 2 9 4
716 76 157 124 115 120
721 141 78 111 172 115
730 43 21 156 63 118
732 179 153 148 159 1
737 58 20 121 4 35
738 46 128 52 65 56
748 32 107 55 14 156
757 142 181 128 170 180
761 139 127 80 158 47
765 152 122 106 106 60
774 33 58 53 85 77
776 25 137 49 107 19
783 156 91 28 141 45
786 151 133 98 165 41
787 15 108 87 64 83
790 74 100 90 36 177
796 175 177 35 145 104
799 162 130 76 43
801 31 69 67 35 129
802 118 74 143 31 64
804 140 25 79 180 154
805 94 31 21 33 55
808 138 180 132 178 149
810 124 84 26 130 140
Line Abl Nrt Abl 1 Abl 4 Rescue
Delta 
14
375 57 76 62 72 96
377 19 29 120 80 98
379 45 170 127 51 162
380 108 147 135 82
381 106 106 167 99 36
382 39 105 153 50 137
383 96 89 116 110 181
385 121 155 139 23 14
386 49 109 17 45 87
390 188 144 150 187 151
391 6 2 125 1 157
392 104 145 123 87 134
395 34 42 82 38 53
397 134 144 108
399 66 121 12 81 27
405 68 50 69 44 148
406 9 45 6 69 70
409 8 37 75 11 136
426 36 70 175 40 102
427 159 146 115 95 75
437 4 9 14 22 46
439 41 8 58 32 20
440 172 17 140 128 89
441 99 139 155 132 16
443 167 110 137 91 85
461 54 82 159 37 128
486 30 93 96 119 23
491 114 166
492 183 11 183 179 79
502 18 56 77 66 26
505 189 77 181 162 81
508 7 79 16 97 31
509 97 23 134 98 6
513 71 54 145 8 58
517 35 53 24 57 113
528 137 160 102 183 80
530 88 13 84 60 123
531 125 43 103 61
535 150 158 94 155 161
551 170 142 164 175 122













Line Abl Nrt Abl 1 Abl 4 Rescue
Delta 
14
812 75 59 92 100 10
818 157 175 138 186 169
819 190 136 109 176 40
820 42 119 101 42 121
821 50 169 100 101 101
822 112 118 108 47 159
832 90 83 174 123 171
837 161 95 162 173 34
843 91 12 23 46 86
850 79 47 61 149 7
852 177 135 131 93 147
853 148 35 119 55 124
855 117 152 57 148 93
857 93 30 41 138 82
859 92 85 40 30 135
861 153 101 27 151 17
879 133 66 19 140 144
880 55
882 135 24 170 90 65
890 127 164 64 96 105
892 44 19 83 15 3
897 85 40 29 25 54
900 114 143 60 109 99
907 89 61 122 20 76
908 178 14 42 83 92
911 158 159 113 62 178
913 20 67 85 19 62
Control 77 99 114 126
Table 2. (continued) 
Table 3. The number of DGRP lines with mean Tb+/Tb- ratios above and below 1.0 for each genotype. 
The percentages of total lines in that genotype that fell into either category was also included. The Dr 
genotype uses mean Dr+/Dr- ratios.  
Genotype Abl Nrt Abl 1 Abl 4 Rescue Delta 14 Dr
# of lines 
with ratio 
below 1.0
120 (63%) 85 (46%) 24 (13%) 102 (54%) 4 (2%) 128 (86%) 
# of lines 
with ratio 
above 1.0





Table 4. The differences between the largest and smallest mean ratio for each genotype, 
as well as the average difference throughout all genotypes.   










Table 5. Variation (s2) of mean ratios within lines in a genotype, variation (s2) between all the lines in a genotype, 
total phenotypic variation (s2), and the percentage of phenotypic variation that can be attributed to genetic 
differences within DGRP lines. Variation within lines was calculated by squaring the mean of individual line 
standard deviations within a genotype. Variation between lines was calculated by taking the standard deviation of 
all mean ratios in a genotype and squaring the value. Total phenotypic variation was calculated by taking the 
standard deviation of all individual ratios in a genotype and squaring the value. Variation due to genetic 
differences is the variation between lines divided by total phenotypic variation. Values were rounded to four 












Abl Nrt 0.0509 0.0028 0.1080 2.56%
Abl 1 0.0257 0.0023 0.0691 3.29%
Abl 4 0.0647 0.0061 0.1398 4.37%
Rescue 0.0350 0.0036 0.0928 3.85%
Delta 14 0.0452 0.0039 0.1108 3.48%


























Figure 1. Mean Tb+/Tb- ratios of Abl Nrt shown in increasing order. Each blue circle represents a single DGRP line. Error bars 




















Abl Nrt Mean Ratios in Increasing Order
Figure 2. Mean Tb+/Tb- ratios of Abl1, Abl4, Rescue, and Delta 14 shown in increasing order. Each blue circle represents a 



















Abl 1 Mean Ratios in Increasing Order
  






















Abl 4 Mean Ratios in Increasing Order












































Delta 14 Mean Ratios in Increasing Order
Figure 3. Mean Dr+/Dr- ratios of Abl Nrt/Dr shown in increasing order. Each blue circle represents a single DGRP line. Error bars 
represent the standard deviation of that line. 
 
  
Abl Nrt vs Abl 4 0.471
Abl Nrt vs Abl 1 0.380
Abl Nrt vs Delta 14 0.170
Abl Nrt vs Rescue 0.623
Abl 1 vs Abl 4 0.244
Abl 1 vs Rescue 0.479
Abl 1 vs Delta 14 0.298
Abl 4 vs Delta 14 0.187
Abl 4 vs Rescue 0.350
Rescue vs Delta 14 0.171
Abl Nrt Tb vs Abl Nrt Dr 0.005
Correlations of mean ratios
Table 6. The correlation of each line’s mean Tb+/Tb- ratio between different genotypes. 


































Figure 4. A graph of Abl Nrt’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Abl 4. 

































Figure 6. A graph of Abl Nrt’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Delta 14. 
Figure 7. A graph of Abl Nrt’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Rescue. 
  
Figure 8. A graph of Abl 1’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Abl 4. 

































Figure 10. A graph of Abl 1’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Delta14. 
Figure 11. A graph of Abl 4’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Delta14. 
  
Figure 12. A graph of Abl 4’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Rescue. 
Figure 13. A graph of Rescue’s mean Tb+/Tb- ratio vs the mean Tb+/Tb- ratio of Delta14. 
 
  





























Genotype SNP Site Annotation Gene p value 
Abl 1 X_10193006_SNP Intron alpha-Man-I 1.15E-06
Abl 1 X_4521824_SNP Intron CG12184 8.99E-06
Abl 1 X_4521853_SNP Intron CG12184 4.25E-06
Abl 1 3R_14723142_SNP Upstream CG14297 3.00E-06
Abl 1 3R_14723267_SNP Upstream CG14297 1.91E-06
Abl 1 3R_14723258_SNP Upstream CG14297 7.05E-07
Abl 1 X_13201576_SNP Downstream CG15745 6.99E-06
Abl 1 3L_1903262_SNP Intron CG1887 9.19E-06
Abl 1 2L_2205183_SNP Non Synonymous Coding CG31668 5.00E-06
Abl 1 3L_7866076_SNP Intron CG32365 1.43E-05
Abl 1 2L_2195621_DEL Intron CG34172 5.79E-06
Abl 1 2L_3198519_DEL Intron CG34393 4.75E-06
Abl 1 3R_10944375_SNP Intron CG42788 7.95E-06
Abl 1 2R_13630036_SNP Synonymous Coding CG4996 4.29E-06
Abl 1 3R_12945910_SNP Intron cher 4.00E-06
Abl 1 X_8901408_SNP Intron CR43836 1.78E-05
Abl 1 3L_21677670_INS Exon CR43978 1.26E-06
Abl 1 2L_4078420_SNP Intron ed 5.03E-06
Abl 1 2R_13198804_SNP Intron mbl 9.82E-06
Abl 1 2R_13198828_SNP Intron mbl 9.82E-06
Abl 1 3L_2743665_SNP Intron Mrtf 7.98E-06
Abl 1 3L_2743681_SNP Intron Mrtf 1.08E-06
Abl 1 2L_14043429_DEL Intron nAcRalpha-34E 1.18E-05
Abl 1 3R_2987891_SNP Upstream sas 9.21E-06
Abl 1 3L_6506233_DEL Intron sfl 2.82E-05
Abl 1 2L_20632586_SNP Intergenic Modifier 2.12E-05
Abl 1 2R_20226597_SNP Intergenic Modifier 2.07E-05
Abl 1 3L_10793231_SNP Intergenic Modifier 1.29E-05
Abl 1 2R_20226558_SNP Intergenic Modifier 1.10E-05
Abl 1 2L_6850647_SNP Intergenic Modifier 7.61E-06
Abl 1 2R_14082654_SNP Intergenic Modifier 6.65E-06
Abl 1 3L_21680814_SNP Intergenic Modifier 4.45E-06
Abl 1 2R_20226667_SNP Intergenic Modifier 3.15E-06
Abl 1 2R_13825524_SNP Intergenic Modifier 1.49E-06
Abl 4 3R_16378803_SNP Intron att-ORFB 1.90E-05
Abl 4 3L_1042346_INS Intron bab1 1.17E-06
Abl 4 X_20946743_SNP Intron bves 9.23E-06
Abl 4 X_19615267_SNP Intron CG12531 1.05E-05
Abl 4 3L_18593750_SNP 3' UTR CG13380 1.29E-05
Abl 4 3L_18593641_SNP 3' UTR CG13380 4.56E-06
Abl 4 3R_7561628_SNP Intron CG14721 9.58E-06
Abl 4 2R_3619580 Intron CG18812 5.88E-06
Abl 4 X_4793872_SNP Intron CG42594 7.01E-06
Abl 4 X_745972_SNP Intron CG43867 3.57E-06






Genotype SNP Site Annotation Gene p value 
Abl 4 2L_8154522_SNP Intron CG8552 1.26E-05
Abl 4 3R_10268936_SNP Intron cv-c 4.47E-06
Abl 4 3L_16436401_SNP Intron dsx-c73A 9.83E-06
Abl 4 3L_9261249_SNP Intron GluRIB 5.43E-06
Abl 4 3L_9260043_SNP Intron GluRIB 1.87E-06
Abl 4 X_16653061_DEL Intron if 8.38E-06
Abl 4 2L_14666405_SNP Intron osp 1.03E-05
Abl 4 2L_14666407_SNP Intron osp 7.65E-06
Abl 4 2L_14666459_SNP Intron osp 7.18E-06
Abl 4 2L_14666419_SNP Intron osp 3.44E-06
Abl 4 2L_14666453_SNP Intron osp 4.08E-07
Abl 4 3R_4939989_SNP Intron pum 1.23E-07
Abl 4 2L_6968058_SNP Upstream smt3 6.46E-06
Abl 4 2L_6968053_SNP Upstream smt3 5.90E-06
Abl 4 2R_15955051_SNP Intergenic Modifier 9.34E-06
Abl 4 3L_6795225_INS Intergenic Modifier 5.91E-06
Abl 4 3L_7194572_SNP Intergenic Modifier 5.13E-06
Abl 4 2L_3443544_SNP Intergenic Modifier 4.71E-06
Abl 4 2L_5515293_SNP Intergenic Modifier 3.19E-06
Abl 4 3L_18579826_SNP Intergenic Modifier 1.21E-06
Abl Nrt 3R_452144_SNP Intron 5-HT2 2.50E-06
Abl Nrt 3R_13081440_INS Intergenic Modifier beat-IIb 3.87E-06
Abl Nrt 2L_15299282_SNP 3' UTR CG15262 7.55E-06
Abl Nrt X_18343963_SNP Intron CG32547 7.64E-06
Abl Nrt X_13439407_SNP Downstream Cpr12A 9.26E-06
Abl Nrt 3L_4081058_DEL Intron Gad1 9.15E-06
Abl Nrt X_19221619_DEL Downstream gfA 1.57E-05
Abl Nrt 2R_2404838_SNP Intron jing 7.56E-07
Abl Nrt 2R_6949002_SNP Intron luna 3.23E-07
Abl Nrt 2R_13131235_INS Intron mbl 5.23E-06
Abl Nrt 3R_5856468_SNP Intron Mical 1.98E-06
Abl Nrt 3L_18641137_SNP Intron MYPT-75D 1.05E-05
Abl Nrt 2L_11882638_SNP Intron Pde1c 9.20E-06
Abl Nrt 2L_11882650_SNP Intron Pde1c 3.16E-06
Abl Nrt 2L_11882664_SNP Intron Pde1c 1.90E-06
Abl Nrt 2R_4545473_SNP Intron ptc 1.31E-05
Abl Nrt 2R_3186402_SNP Synonymous Coding pwn 3.03E-06
Abl Nrt 3L_5895489_SNP Synonymous Coding QC 5.07E-06
Abl Nrt 3L_5895517_SNP Non Synonymous Coding QC 3.29E-06
Abl Nrt 3L_5895533_SNP 5' UTR QC 2.45E-06
Abl Nrt 2R_19527421_SNP Intron retn 8.30E-06
Abl Nrt 2R_14824531_SNP Intron sano 7.82E-06
Abl Nrt 2R_14824549_SNP Intron sano 9.00E-08
Abl Nrt 2L_19814596_SNP Intron sick 5.71E-06
Table 7. (continued).  
 
  
Genotype SNP Site Annotation Gene p value 
Abl Nrt 2L_6232623_SNP Intergenic Modifier 5.96E-06
Abl Nrt 2R_4520739_SNP Intergenic Modifier 5.60E-06
Abl Nrt 2R_4520738_SNP Intergenic Modifier 4.61E-06
Abl Nrt 2L_12576072_SNP Intergenic Modifier 2.25E-06
Delta14 2R_5995863_SNP Downstream 14-3-3zeta 2.05E-06
Delta14 X_3478978_SNP Intron AlstR 1.93E-05
Delta14 X_3478986_SNP Intron AlstR 6.82E-06
Delta14 2L_19769020_SNP Upstream bsh 6.59E-07
Delta14 2L_5808191_SNP Synonymous Coding CG11034 1.11E-05
Delta14 2L_5808173_SNP Synonymous Coding CG11034 8.62E-06
Delta14 3R_9679352_SNP Downstream CG14362 3.57E-05
Delta14 X_6125243_SNP Synonymous Coding CG14446 5.26E-06
Delta14 X_21064284_SNP 5' UTR CG14579 2.71E-05
Delta14 X_21064242_SNP Upstream CG14579 2.01E-05
Delta14 X_10225342_SNP Synonymous Coding CG15306 7.81E-06
Delta14 3L_7863864_SNP Intron CG32365 9.80E-06
Delta14 2L_6128168_SNP 3' UTR CG42730 2.82E-05
Delta14 2R_6252189_SNP Intron CG42732 2.19E-05
Delta14 2L_18242977_DEL Intron CG42750 3.62E-06
Delta14 3R_4415464_SNP Intron CG42796 5.98E-06
Delta14 3L_16491090_SNP Intron CG43373 7.20E-06
Delta14 X_10061190_DEL Intron CG43902 4.24E-06
Delta14 X_10061189_SNP Intron CG43902 1.79E-06
Delta14 2R_6671828_SNP Intron CG44299 2.96E-06
Delta14 2R_13680251_SNP Upstream CG5036 3.55E-09
Delta14 2L_5773913_INS Intron CG9171 8.52E-07
Delta14 2R_18160451_SNP Intron dve 2.69E-06
Delta14 2L_5556123_SNP Synonymous Coding GluRIIA 9.13E-06
Delta14 2L_1013523_SNP 3' UTR IA-2 3.94E-05
Delta14 2R_6397049_SNP Downstream lola 8.34E-06
Delta14 2R_6397130_SNP Downstream lola 8.34E-06
Delta14 2R_9962168_SNP Intron Prosap 8.84E-06
Delta14 2R_6448839_SNP Intron psq 2.76E-07
Delta14 2L_7520090_ Intron Rapgap1 1.20E-05
Delta14 3L_4917435_SNP Intron Rh50 3.94E-06
Delta14 3L_8549157_SNP Intron rhea 2.24E-07
Delta14 3L_15908998_SNP Intron sff 9.87E-06
Delta14 3L_7259421_SNP 3' UTR unc-13-4A 4.25E-06
Delta14 2L_989924_SNP Intergenic Modifier 3.01E-05
Delta14 3L_6261365_SNP Intergenic Modifier 2.61E-05
Delta14 2R_10602584_SNP Intergenic Modifier 2.01E-05
Delta14 2R_6442595_SNP Intergenic Modifier 1.64E-05
Delta14 3L_6636135_SNP Intergenic Modifier 1.36E-05
Delta14 2R_16265426_SNP Intergenic Modifier 8.97E-06
Table 7. (continued).  
  
Genotype SNP Site Annotation Gene p value 
Delta14 3L_6263512_SNP Intergenic Modifier 8.95E-06
Delta14 X_22220738_SNP Intergenic Modifier 6.19E-06
Delta14 3L_9235814_DEL Intergenic Modifier 6.14E-06
Delta14 X_22220947_SNP Intergenic Modifier 5.84E-06
Delta14 X_5405646_SNP Intergenic Modifier 5.74E-06
Delta14 2L_19288915_SNP Intergenic Modifier 4.27E-06
Delta14 3L_6266317_SNP Intergenic Modifier 3.52E-06
Delta14 2L_19290707_SNP Intergenic Modifier 3.25E-06
Delta14 2L_19290709_SNP Intergenic Modifier 9.86E-07
Delta14 2R_17666060_SNP Intergenic Modifier 6.28E-07
Rescue 2L_13935475_SNP Intron Ance-3 8.30E-06
Rescue 2L_13935478_SNP Intron Ance-3 5.41E-06
Rescue 2L_13935547_SNP Intron Ance-3 4.29E-06
Rescue 2L_13935530_SNP Intron Ance-3 3.63E-06
Rescue 2L_12177013_DEL Intron atilla 6.17E-08
Rescue 3R_6152798_SNP Non Synonymous Coding Bruce 3.13E-06
Rescue 2R_10733938_SNP Synonymous Coding CG10209 1.58E-06
Rescue 2L_12759949_SNP Downstream CG15483 1.19E-06
Rescue 3L_1903264_DEL Intron CG1887 2.59E-06
Rescue 3L_13056820_SNP Intron CG34429 1.24E-05
Rescue 3L_17627550_SNP Intron CG7497 3.05E-06
Rescue 3R_10219158_SNP Non Synonymous Coding cv-c 7.43E-06
Rescue X_3705492_SNP Upstream ec 8.66E-06
Rescue 3L_14341635_SNP Intron fz 4.98E-06
Rescue 3R_6367531_SNP Intron hth 4.83E-06
Rescue 3L_5374763_SNP Intron Ir64a 4.80E-06
Rescue 3L_5374692_INS Intron Ir64a 2.64E-07
Rescue 2L_18130113_SNP 3' UTR kel 8.32E-06
Rescue 2L_6152446_SNP Synonymous Coding Muc26B 2.45E-06
Rescue 2L_6152028_SNP 5' UTR Muc26B 1.09E-08
Rescue 2L_6152034_SNP 5' UTR Muc26B 1.08E-08
Rescue 3R_12998339_SNP Intron Mur89F 5.47E-06
Rescue 2L_11882664_SNP Intron Pde1c 1.35E-06
Rescue 2L_11882650_SNP Intron Pde1c 6.99E-07
Rescue 2R_10207978_SNP Intron Shroom 2.94E-06
Rescue 3L_5691605_SNP Intron sif 8.54E-06
Rescue X_5256297_SNP Intron SK 1.04E-05
Rescue X_5256299_SNP Intron SK 1.04E-05
Rescue 3L_11679041_SNP Intron Sug 5.82E-06
Rescue 3L_11679933_SNP Synonymous Coding Sug 4.05E-06
Rescue 3L_11679811_SNP Intron Sug 4.77E-08
Rescue 2L_3104089_SNP Intron toc 9.83E-06
Rescue 2L_6003150_SNP 3' UTR Tsp26A 2.38E-06
Rescue 3R_9708318_SNP Intergenic Modifier 1.01E-05



















Genotype SNP Site Annotation Gene p value 
Rescue 3L_15662022_SNP Intergenic Modifier 9.52E-06
Rescue 3R_10785767_SNP Intergenic Modifier 8.95E-06
Rescue 3L_15660911_SNP Intergenic Modifier 8.10E-06
Rescue 2L_12767079_SNP Intergenic Modifier 7.47E-06
Rescue 3L_15660667_SNP Intergenic Modifier 6.66E-06
Rescue 2R_12735629_SNP Intergenic Modifier 4.91E-06
Rescue 2L_14532447_SNP Intergenic Modifier 3.58E-06
Rescue 2L_12762869_SNP Intergenic Modifier 3.05E-06
Rescue 2L_12766472_SNP Intergenic Modifier 6.42E-07
Rescue 2L_12765670_SNP Intergenic Modifier 2.21E-07
Rescue 2L_12764490_SNP Intergenic Modifier 1.30E-07
Table 7. (continued).  
Table 8. Genes where SNPs occurred that were shared between genotypes.   
Genotype SNP Site Annotation Gene p value 
Abl 1 3L_1903262_SNP Intron CG1887 9.19E-06
Rescue 3L_1903264_DEL Intron CG1887 2.59E-06
Abl 1 3L_7866076_SNP Intron CG32365 1.43E-05
Delta14 3L_7863864_SNP Intron CG32365 9.80E-06
Abl 4 3R_10268936_SNP Intron cv-c 4.47E-06
Rescue 3R_10219158_SNP Non Synonymous Coding cv-c 7.43E-06
Abl 1 2R_13198804_SNP Intron mbl 9.82E-06
Abl 1 2R_13198828_SNP Intron mbl 9.82E-06
Abl Nrt 2R_13131235_INS Intron mbl 5.23E-06
Abl Nrt 2L_11882664_SNP Intron Pde1c 1.90E-06
Abl Nrt 2L_11882650_SNP Intron Pde1c 3.16E-06
Abl Nrt 2L_11882638_SNP Intron Pde1c 9.20E-06
Rescue 2L_11882650_SNP Intron Pde1c 6.99E-07
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